Atrial septal defect in adulthood: a new paradigm for congenital heart disease

Margarita Brida1,2,3, Massimo Chessa4,5, David Celermajer6

  • 1Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton & Harefield Hospitals, National Heart and Lung Institute, Imperial College, Sydney Street, London SW3 6NP, UK.

European Heart Journal
|September 18, 2021
PubMed

Insights

Atrial septal defects (ASDs), common in adults, present complex diagnostic and treatment challenges. This review details optimal management strategies for ASDs, including closure options and managing complications like arrhythmias and pulmonary arterial hypertension.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Adult Congenital Heart Disease

Background:

  • Atrial septal defects (ASDs) are the most frequent congenital heart defect diagnosed in adults.
  • Despite being considered simple, ASDs exhibit anatomical heterogeneity and lead to complications such as arrhythmias, thromboembolism, right heart failure, and pulmonary arterial hypertension (PAH).

Purpose of the Study:

  • To provide clinicians with an updated review on the latest evidence regarding ASD diagnosis and management.
  • To discuss the nuances of optimal diagnostic approaches, treatment strategies, and long-term follow-up for adult patients with ASDs.

Main Methods:

  • Literature review focusing on recent advancements in ASD diagnosis and treatment.
  • Analysis of current guidelines and clinical evidence for managing ASD-related complications.

Main Results:

  • ASD management requires specialized expertise, considering options like catheter or surgical closure.
  • Pre-closure ablation may be indicated for atrial tachycardia, while PAH necessitates targeted therapy or closure suitability assessment.

Conclusions:

  • Optimal ASD care involves a multidisciplinary approach, addressing anatomical variations and potential complications.
  • This review emphasizes the importance of tailored treatment plans and vigilant long-term follow-up for adult ASD patients.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
84
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
1.4K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
82
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
77
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
96
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
105